Drug intelligence / Profile preview

anti-Trop-2 antibody-indocyanine green conjugate

Development stage
Unknown
Lead developer
University Medical Center Groningen
Modality
Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

The anti-Trop-2 antibody-indocyanine green conjugate is a diagnostic imaging agent designed for fluorescence-guided surgery (FGS). It consists of a monoclonal antibody specific for the Trophoblast cell-surface antigen 2 (Trop-2) covalently linked to indocyanine green (ICG), a near-infrared (NIR) fluorescent dye. Trop-2 is a transmembrane glycoprotein that is significantly overexpressed in a wide variety of epithelial carcinomas, including breast, lung, and pancreatic cancers, while showing limited expression in normal tissues. Upon intravenous administration, the conjugate selectively accumulates in Trop-2-expressing tumor cells. During surgical procedures, the ICG component emits fluorescence when excited by NIR light, allowing surgeons to visualize tumor margins, identify micrometastases, and detect lymph node involvement in real-time. This technology aims to improve surgical precision, ensure complete tumor resection, and minimize damage to adjacent healthy structures.

Other names
anti-Trop-2-mAb-ICGanti-Trop2-mAb-ICGanti-Trop 2-mAb-ICGanti-Trop-2-ICG conjugateanti-Trop2-ICG conjugateanti-Trop 2-ICG conjugate
02

Targets

TACSTD2 (Tumor-associated calcium signal transducer 2)

Beyond the preview

Go deeper on anti-Trop-2 antibody-indocyanine green conjugate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-Trop-2 antibody-indocyanine green conjugate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call